详情页 - 河北医科大学第四医院机构库

资源类型：

文章类型：

作者：

Luo, Huiyan[1] * ; Lu, Jin[2] ; Bai, Yuxian[3] ; Mao, Teng[4] ; Wang, Jun[5]

; Fan, Qingxia[6] ; Zhang, Yiping[7] ; Zhao, Kuaile[8] ; Chen, Zhendong[9] ; Gao, Shegan[10] ; Li, Jiancheng[11] ; Fu, Zhichao[12] ; Gu, Kangsheng[13] ; Liu, Zhihua[14] ; Wu, Lin[15] ; Zhang, Xiaodong[16] ; Feng, Jifeng[17] ; Sheng, Zhen[18] ; Zeng, Wanqin[18] ; Xu, Rui-Hua[1] ;

机构： [1]Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Ctr Canc, Guangzhou, Peoples R China [2]Sichuan Canc Hosp, Chengdu, Peoples R China [3]Harbin Med Univ Canc Hosp, Dept Gastroenterol, Harbin, Peoples R China [4]Shanghai Chest Hosp, Shanghai, Peoples R China [5]Hebei Med Univ, Hosp 4, Shijiazhuang, Peoples R China [6]Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China [7]Zhejiang Canc Hosp, Hangzhou, Peoples R China [8]Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China [9]Anhui Med Univ, Dept Oncol, Affiliated Hosp 2, Hefei, Peoples R China [10]Henan Univ Sci & Technol, Affiliated Hosp 1, Luoyang, Peoples R China [11]Fujian Prov Canc Hosp, Fuzhou, Peoples R China [12]900 Hosp Joint Logist Support Force, Fuzhou, Peoples R China [13]Anhui Med Univ, Affiliated Hosp 1, Hefei, Peoples R China [14]Jiangxi Canc Hosp, Nanchang, Peoples R China [15]Hunan Canc Hosp, Changsha, Peoples R China [16]Peking Univ Canc Hosp & Inst, Beijing, Peoples R China [17]Jiangsu Canc Hosp, Nanjing, Peoples R China [18]Jiangsu Hengrui Pharmaceut Co Ltd, Shanghai, Peoples R China

出处：

ISSN：

基金：

语种：

WOS：

中科院分区：

出版当年[2025]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

JCR分区：

出版当年[2024]版：

无

最新[2023]版：

Q1 ONCOLOGY

第一作者：

第一作者机构： [1]Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Ctr Canc, Guangzhou, Peoples R China

推荐引用方式(GB/T 7714)：

APA：

MLA：

Final analysis of the randomized phase 3 ESCORT-1st trial: Camrelizumab plus chemotherapy as first-line treatment for advanced or metastatic esophageal squamous cell carcinoma

文献详情